Cargando…

Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)

OBJECTIVE: Diabetes has been growing as a major health problem and a significant burden on the population and on health systems of developing countries like Mexico that are also ageing fast. The goal of the study was to estimate the future prevalence of diabetes among Mexico’s older adults to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Gonzalez, Cesar, Tysinger, Bryan, Goldman, Dana P, Wong, Rebeca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665264/
https://www.ncbi.nlm.nih.gov/pubmed/29074514
http://dx.doi.org/10.1136/bmjopen-2017-017330
_version_ 1783275130225426432
author Gonzalez-Gonzalez, Cesar
Tysinger, Bryan
Goldman, Dana P
Wong, Rebeca
author_facet Gonzalez-Gonzalez, Cesar
Tysinger, Bryan
Goldman, Dana P
Wong, Rebeca
author_sort Gonzalez-Gonzalez, Cesar
collection PubMed
description OBJECTIVE: Diabetes has been growing as a major health problem and a significant burden on the population and on health systems of developing countries like Mexico that are also ageing fast. The goal of the study was to estimate the future prevalence of diabetes among Mexico’s older adults to assess the current and future health and economic burden of diabetes. DESIGN: A simulation study using longitudinal data from three waves (2001, 2003 and 2012) of the Mexican Health and Aging Study and adapting the Future Elderly Model to simulate four scenarios of hypothetical interventions that would reduce diabetes incidence and to project the future diabetes prevalence rates among populations 50 years and older. PARTICIPANTS: Data from 14 662 participants with information on self-reported diabetes, demographic characteristics, health and mortality. OUTCOME MEASURES: We obtained, for each scenario of diabetes incidence reduction, the following summary measures for the population aged 50 and older from 2012 to 2050: prevalence of diabetes, total population with diabetes, number of medical visits. RESULTS: In 2012, there were approximately 20.7 million persons aged 50 and older in Mexico; 19.3% had been diagnosed with diabetes and the 2001–2003 diabetes incidence was 4.3%. The no-intervention scenario shows that the prevalence of diabetes is projected to increase from 19.3% in 2012 to 34.0% in 2050. Under the 30% incidence reduction scenario, the prevalence of diabetes will be 28.6% in 2050. Comparing the no-intervention scenario with the 30% and 60% diabetes incidence reduction scenarios, we estimate a total of 816 320 and 1.6 million annual averted cases of diabetes, respectively, for the year 2020. DISCUSSION: Our study underscores the importance of diabetes as a disease by itself and also the potential healthcare demands and social burden of this disease and the need for policy interventions to reduce diabetes prevalence.
format Online
Article
Text
id pubmed-5665264
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56652642017-11-15 Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico) Gonzalez-Gonzalez, Cesar Tysinger, Bryan Goldman, Dana P Wong, Rebeca BMJ Open Diabetes and Endocrinology OBJECTIVE: Diabetes has been growing as a major health problem and a significant burden on the population and on health systems of developing countries like Mexico that are also ageing fast. The goal of the study was to estimate the future prevalence of diabetes among Mexico’s older adults to assess the current and future health and economic burden of diabetes. DESIGN: A simulation study using longitudinal data from three waves (2001, 2003 and 2012) of the Mexican Health and Aging Study and adapting the Future Elderly Model to simulate four scenarios of hypothetical interventions that would reduce diabetes incidence and to project the future diabetes prevalence rates among populations 50 years and older. PARTICIPANTS: Data from 14 662 participants with information on self-reported diabetes, demographic characteristics, health and mortality. OUTCOME MEASURES: We obtained, for each scenario of diabetes incidence reduction, the following summary measures for the population aged 50 and older from 2012 to 2050: prevalence of diabetes, total population with diabetes, number of medical visits. RESULTS: In 2012, there were approximately 20.7 million persons aged 50 and older in Mexico; 19.3% had been diagnosed with diabetes and the 2001–2003 diabetes incidence was 4.3%. The no-intervention scenario shows that the prevalence of diabetes is projected to increase from 19.3% in 2012 to 34.0% in 2050. Under the 30% incidence reduction scenario, the prevalence of diabetes will be 28.6% in 2050. Comparing the no-intervention scenario with the 30% and 60% diabetes incidence reduction scenarios, we estimate a total of 816 320 and 1.6 million annual averted cases of diabetes, respectively, for the year 2020. DISCUSSION: Our study underscores the importance of diabetes as a disease by itself and also the potential healthcare demands and social burden of this disease and the need for policy interventions to reduce diabetes prevalence. BMJ Publishing Group 2017-10-25 /pmc/articles/PMC5665264/ /pubmed/29074514 http://dx.doi.org/10.1136/bmjopen-2017-017330 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Diabetes and Endocrinology
Gonzalez-Gonzalez, Cesar
Tysinger, Bryan
Goldman, Dana P
Wong, Rebeca
Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
title Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
title_full Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
title_fullStr Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
title_full_unstemmed Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
title_short Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
title_sort projecting diabetes prevalence among mexicans aged 50 years and older: the future elderly model-mexico (fem-mexico)
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665264/
https://www.ncbi.nlm.nih.gov/pubmed/29074514
http://dx.doi.org/10.1136/bmjopen-2017-017330
work_keys_str_mv AT gonzalezgonzalezcesar projectingdiabetesprevalenceamongmexicansaged50yearsandolderthefutureelderlymodelmexicofemmexico
AT tysingerbryan projectingdiabetesprevalenceamongmexicansaged50yearsandolderthefutureelderlymodelmexicofemmexico
AT goldmandanap projectingdiabetesprevalenceamongmexicansaged50yearsandolderthefutureelderlymodelmexicofemmexico
AT wongrebeca projectingdiabetesprevalenceamongmexicansaged50yearsandolderthefutureelderlymodelmexicofemmexico